Details for New Drug Application (NDA): 020740
✉ Email this page to a colleague
The generic ingredient in BAYCOL is cerivastatin sodium. Additional details are available on the cerivastatin sodium profile page.
Summary for 020740
Tradename: | BAYCOL |
Applicant: | Bayer Pharms |
Ingredient: | cerivastatin sodium |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.05MG | ||||
Approval Date: | Jun 26, 1997 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.1MG | ||||
Approval Date: | Jun 26, 1997 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.2MG | ||||
Approval Date: | Jun 26, 1997 | TE: | RLD: | No |
Expired US Patents for NDA 020740
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bayer Pharms | BAYCOL | cerivastatin sodium | TABLET;ORAL | 020740-006 | Jul 24, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Bayer Pharms | BAYCOL | cerivastatin sodium | TABLET;ORAL | 020740-001 | Jun 26, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Bayer Pharms | BAYCOL | cerivastatin sodium | TABLET;ORAL | 020740-002 | Jun 26, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription